Product Information
- 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane
- cyclic peptide deriv.
- BIM 23014C
- Somatulina
- Somatuline,L-Threoninamide
- 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-
- cyclic (2?7)-disulfide
- acetate (salt) (9CI)
- 10-(4-Aminobutyl)-19-[(2-Amino-3-Naphthalen-2-Yl-Propanoyl)Amino]-N-(1-Carbamoyl-2-Hydroxy-Propyl)-16-[(4-Hydroxyphenyl)Methyl]-13-(1H-Indol-3-Ylmethyl)-6,9,12,15,18-Pentaoxo-7-Propan-2-Yl-1,2-Dithia-5,8,11,14,17-Pentazacycloicosane-4-Carboxamide
Applications Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma.
References Kuehnen, P. et al.: Horm. Res. Paediat., 78, 106 (2012); Li, Z. et al.: J. Int. Med. Res., 40, 517 (2012);
Chemical properties
Technical inquiry about: TR-L174600 Lanreotide Acetate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.